Literature DB >> 17785208

A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.

Masumichi Saito1, Jie Gao, Katia Basso, Yukiko Kitagawa, Paula M Smith, Govind Bhagat, Alessandra Pernis, Laura Pasqualucci, Riccardo Dalla-Favera.   

Abstract

The BCL6 proto-oncogene encodes a transcriptional repressor necessary for the development of germinal centers (GCs) and directly implicated in lymphomagenesis. Post-GC development of B cells requires BCL6 downregulation, while its constitutive expression caused by chromosomal translocations leads to diffuse large B cell lymphoma (DLBCL). Herein we identify a signaling pathway that downregulates BCL6 expression in normal GC B cells and is blocked in a subset of DLBCL due to alterations in the BCL6 gene. Activation of the CD40 receptor leads to NF-kappaB-mediated induction of the IRF4 transcription factor, which, in turn, represses BCL6 expression by binding to its promoter region. A subset of DLBCL displays chromosomal translocations or mutations that disrupt the IRF4-responsive region in the BCL6 promoter and block its downregulation by CD40 signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785208     DOI: 10.1016/j.ccr.2007.08.011

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  169 in total

Review 1.  Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification.

Authors:  Elaine S Jaffe; Stefania Pittaluga
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

2.  Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis.

Authors:  María Rodríguez Martínez; Alberto Corradin; Ulf Klein; Mariano Javier Álvarez; Gianna M Toffolo; Barbara di Camillo; Andrea Califano; Gustavo A Stolovitzky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression.

Authors:  Shibin Ma; Simanta Pathak; Malay Mandal; Long Trinh; Marcus R Clark; Runqing Lu
Journal:  Mol Cell Biol       Date:  2010-06-21       Impact factor: 4.272

Review 4.  Pathogenesis of diffuse large B cell lymphoma.

Authors:  Wing John C Chan
Journal:  Int J Hematol       Date:  2010-06-29       Impact factor: 2.490

5.  Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas.

Authors:  Anna Bolduc; Eugene Long; Dale Stapler; Marilia Cascalho; Takeshi Tsubata; Pandelakis A Koni; Michiko Shimoda
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

Review 6.  Control systems and decision making for antibody production.

Authors:  Christopher C Goodnow; Carola G Vinuesa; Katrina L Randall; Fabienne Mackay; Robert Brink
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

7.  IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells.

Authors:  B Belinda Ding; Enguang Bi; Hongshan Chen; J Jessica Yu; B Hilda Ye
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

8.  CD40L is transferred to antigen-presenting B cells during delivery of T-cell help.

Authors:  Jennifer L Gardell; David C Parker
Journal:  Eur J Immunol       Date:  2016-11-28       Impact factor: 5.532

9.  BCL6--regulated by AhR/ARNT and wild-type MEF2B--drives expression of germinal center markers MYBL1 and LMO2.

Authors:  Jie Ding; Wilhelm G Dirks; Stefan Ehrentraut; Robert Geffers; Roderick A F MacLeod; Stefan Nagel; Claudia Pommerenke; Julia Romani; Michaela Scherr; Lea A I Vaas; Margarete Zaborski; Hans G Drexler; Hilmar Quentmeier
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

10.  TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.

Authors:  Pilar M Dominguez; Hussein Ghamlouch; Wojciech Rosikiewicz; Parveen Kumar; Wendy Béguelin; Lorena Fontán; Martín A Rivas; Patrycja Pawlikowska; Marine Armand; Enguerran Mouly; Miguel Torres-Martin; Ashley S Doane; María T Calvo Fernandez; Matt Durant; Veronique Della-Valle; Matt Teater; Luisa Cimmino; Nathalie Droin; Saber Tadros; Samaneh Motanagh; Alan H Shih; Mark A Rubin; Wayne Tam; Iannis Aifantis; Ross L Levine; Olivier Elemento; Giorgio Inghirami; Michael R Green; Maria E Figueroa; Olivier A Bernard; Said Aoufouchi; Sheng Li; Rita Shaknovich; Ari M Melnick
Journal:  Cancer Discov       Date:  2018-10-01       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.